An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic Fibrosis.
Paul TappendenSusannah SadlerMartin WildmanPublished in: PharmacoEconomics (2018)
If effective, the adherence intervention is expected to produce additional health gains at a lower cost than current CF care. However, the economic analysis should be revisited upon completion of the full RCT. More generally, the analysis suggests that considerable gains could be accrued through the implementation of adherence interventions that shift care from expensive hospital-based rescue to community-based prevention.
Keyphrases
- healthcare
- cystic fibrosis
- randomized controlled trial
- public health
- quality improvement
- palliative care
- mental health
- pseudomonas aeruginosa
- primary care
- physical activity
- glycemic control
- type diabetes
- human health
- metabolic syndrome
- lung function
- adipose tissue
- chronic obstructive pulmonary disease
- risk assessment
- climate change